Vitaliy Gavrilyuk
Affiliations: | University of Illinois at Chicago, Chicago, IL, United States |
Area:
Molecular BiologyGoogle:
"Vitaliy Gavrilyuk"Mean distance: 18.5 (cluster 31) | S | N | B | C | P |
Cross-listing: Neurotree
Parents
Sign in to add mentor| Douglas L. Feinstein | grad student | 1998-2003 | University of Illinois, Chicago (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Akar C, Kalinin S, Gavrilyuk V, et al. (2010) Receptor-independent metabolic effects of thiazolidinediones in astrocytes Open Cancer Immunology Journal. 3: 36-40 |
| Feinstein DL, Brosnan CF, Whitacre CC, et al. (2008) PPAR-agonists prevent experimental autoimmune encephalomyelitis Journal of Neurochemistry. 81: 36-36 |
| Dello Russo C, Gavrilyuk V, Feinstein DL. (2008) Inter-relationship of cytokine production and NOS2 expression in microglia Journal of Neurochemistry. 81: 52-53 |
| Kalinin S, Gavrilyuk V, Polak PE, et al. (2007) Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease. Neurobiology of Aging. 28: 1206-14 |
| Phulwani NK, Feinstein DL, Gavrilyuk V, et al. (2006) 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway. Journal of Neurochemistry. 99: 1389-1402 |
| Madrigal JL, Dello Russo C, Gavrilyuk V, et al. (2006) Effects of noradrenaline on neuronal NOS2 expression and viability. Antioxidants & Redox Signaling. 8: 885-92 |
| Kalinin S, Polak PE, Madrigal JL, et al. (2006) Beta-amyloid-dependent expression of NOS2 in neurons: prevention by an alpha2-adrenergic antagonist. Antioxidants & Redox Signaling. 8: 873-83 |
| Polak PE, Kalinin S, Dello Russo C, et al. (2005) Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 168: 65-75 |
| Feinstein DL, Spagnolo A, Akar C, et al. (2005) Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key? Biochemical Pharmacology. 70: 177-88 |
| Gavrilyuk V, Kalinin S, Hilbush BS, et al. (2005) Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties. Journal of Neurochemistry. 92: 1140-9 |